tiprankstipranks
Trending News
More News >
Ascom Holding AG (CH:ASCN)
:ASCN

Ascom Holding AG (ASCN) AI Stock Analysis

Compare
2 Followers

Top Page

CH:ASCN

Ascom Holding AG

(ASCN)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
CHF4.00
▲(4.71% Upside)
The score is driven primarily by mixed financial performance: balance-sheet strength and improved free cash flow are positive, but the sharp 2024 earnings and margin deterioration weighs heavily. Technicals are supportive with the stock trading above key moving averages and a positive MACD, while valuation remains a notable risk due to a high P/E despite a moderate dividend yield.

Ascom Holding AG (ASCN) vs. iShares MSCI Switzerland ETF (EWL)

Ascom Holding AG Business Overview & Revenue Model

Company DescriptionAscom Holding AG, together with its subsidiaries, provides healthcare ICT and mobile workflow solutions worldwide. The company offers nurse call and monitoring systems, including teleCARE IP that provides nurse call, alerts, messaging, monitoring, and wander management solution; and Telligence, a patient response system. It also provides Digistat software, suite of clinical workflows; Unite software, a workflow orchestration platform that integrates data and events from source systems, as well as alerts, chats, and tasks to enable users on various endpoint platforms. In addition, the company provides mobile devices, DECT and VoWiFi handsets, pagers, and IP-DECT solutions. Further, it offers consulting, implementation, training, support, and maintenance services. The company offers its solutions for hospitals acute care facilities; enterprises, including retail, security, and hospitality industries; and long-term care facilities. The company is headquartered in Baar, Switzerland.
How the Company Makes Money

Ascom Holding AG Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue284.60M286.70M297.30M297.40M291.50M281.00M
Gross Profit133.30M133.30M141.40M135.40M135.60M131.90M
EBITDA15.40M13.80M31.30M25.90M28.80M25.20M
Net Income3.00M3.70M17.40M11.00M13.50M6.50M
Balance Sheet
Total Assets190.50M189.90M197.20M201.80M194.70M203.10M
Cash, Cash Equivalents and Short-Term Investments29.50M18.60M24.70M26.60M29.50M31.80M
Total Debt0.000.000.0010.00M0.0019.00M
Total Liabilities118.30M115.50M118.50M128.40M114.70M132.00M
Stockholders Equity72.20M74.40M78.70M73.40M80.00M71.10M
Cash Flow
Free Cash Flow27.50M15.60M16.30M-3.20M-100.00K34.40M
Operating Cash Flow29.90M20.00M32.50M10.20M11.60M45.10M
Investing Cash Flow-11.70M-15.50M-16.20M-14.00M5.20M-10.00M
Financing Cash Flow-9.50M-10.80M-17.20M2.20M-19.00M-21.10M

Ascom Holding AG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
CHF1.19B-2,219.397.29%-112.70%
61
Neutral
CHF131.91M43.894.02%2.75%
56
Neutral
CHF476.99M-81.244.54%-2.42%-222.68%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CH:ASCN
Ascom Holding AG
3.67
-0.38
-9.46%
MEDGF
Medacta Group SA
211.66
93.97
79.84%
SGFEF
Siegfried Holding AG
104.61
-1.72
-1.62%
DE:283
IVF HARTMANN Holding AG
153.00
23.66
18.29%
CH:MEDX
medmix AG
11.56
1.57
15.72%
CH:MED
Medartis Holding AG
87.00
22.70
35.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 04, 2026